Introduction
No records exist of patients surviving furious rabies encephalitis. The three reports of recovery from rabies followed predominantly paralytic illnesses. 4 The diagnosis rested on high concentrations of antibody to the rabies virus in serum and cerebrospinal fluid, but no rabies virus or antigen was detected. Further attempts at intensive care have failed to save patients with rabies.;-2 Clearly, additional therapeutic approaches are necessary.
Interferon prevents replication of the rabies virus in vitro,'" and a single dose of an interferon inducer given 24 hours after inoculation of the virus protects rabbits against rabies.' Treatment with interferon from human leucocytes affords protection of infected monkeys even if given 11 days after rabies inoculation. Furthermore, interferon treatment has been most effective when given by combined intramuscular and intralumbar routes in monkeys.' Although endogenous interferon has been detected in some humans with rabies, the concentrations were very low, even in brain tissue sampled at necropsy." Treatment with exogenous interferon has been ineffective if used late in the illness6 '9 so we treated patients with early rabies encephalitis with high doses of interferon alfa.
Tribavirin, which selectively blocks the synthesis of viral guanosine nucleotides, is effective against rabies virus, in vitro.20 Protection the Namalwa human lymphoblastoid cell line (Wellferon batch CIN/4, Wellcome Foundation) was given intravenously at a loading dose of 50 MU/mr body surface infused over six hours. This was repeated over the next 18 hours and then given daily as a continuous intravenous infusion. The intravenous solution was stabilised by the addition of human albumin 1 5 mg/ml except in the first patient. The first dose of intrathecal interferon was given by the lumbar route, and thereafter it was given into the cerebral ventricle by the Ommaya reservoir. A loading dose of 2 MU/m2 was repeated after six hours and then daily. For the third patient the dose was halved after the first week. Samples of serum and cerebrospinal fluid were stored at -70°C for assav of interferon alfa with a Cell-Tec radioimmunoassav kit.
Tribavirin treatment-Tribavirin (Viratek, United States) was given intravenously as a loading dose of 2 g (30 mg/kg) over 20 minutes followed by 1 g six hourly 
Results
Three patients were treated with interferon and one with tribavirin, but all died between five and 12 days after starting treatment. Table I shows the nature of  their exposure to rabies infection and table II their  clinical features. Virological examination- Table III shows the results of detection and isolation of rabies virus and serological tests. The skin biopsy method of detecting antigen confirmed the diagnosis during life in every case and gave a positive result on admission in three patients. The corneal smear test yielded negative results in all patients on every occasion. The virus was isolated from the brain biopsy specimens taken from all patients during insertion of the Ommaya reservoir, but no antigen was detected by the immunofluorescence antibody test in the specimen from the second patient. The needle biopsy brain specimens taken at necropsy contained large amounts of rabies antigen detected by imniunofluorescence, and the virus grew readily in suckling mice. The sample from the fourth patierrt was inoculated on to mouse neuroblastoma cells, and after three days half of the cells were infected, indicating a high virus titre in the brain inoculum. Only the third patient had any detectable rabies antibody (table IV) . Neutralising antibody and rabies specific IgM appeared during the second week of illness. Interferon concentrations-The first and second patients had no detectable interferon (<62 IU/ml) before treatment, but endogenous interferon 80 IU/ml was found in the cerebrospinal fluid of the third patient. The figure shows the high interferon concentrations in serum and ventricular cerebrospinal fluid for each patient. The cerebrospinal fluid samples were obtained before treatment and so gave trough concentrations. 
Analysis of cerebrospinal fluid on admission-The changes in the lumbar cerebrospinal fluid were minor. The first and second patients had 20000 and 4000 lymphocytes per litre respectively. No abnormalities in total protein and glucose concentrations were detected, and the IgG indices and albumin quotients were normal, indicating no intrathecal production of IgG or leak across the blood-brain barrier.
Histopathological examination of the cerebral cortex biopsy specimens taken on admission showed only minor, non-specific changes in three cases, but the specimen from the third patient showed Negri bodies and some perivascular mononuclear cell infiltration. In needle biopsy samples taken at necropsy, however, Negri bodies were found in all except the third patient, indicating how focal the pathological changes may be. Perivascular infiltration by mononuclear cells and microglial reaction were often seen, and sparse neuronophagia, demyelination, and petechial haemorrhages were occasionally seen.
Haematological and biochemical changes possibly caused by treatment-The first patient had no haematological or biochemical abnormality suggesting interferon toxicity, though the white cell counts of the second and third patients fell to about 3 x I09/l in five days but returned to about 10 x 1I09/l before death. The serum potassium concentration of the second patient rose to 9 8 mmol/l before death, which was associated with creatinine concentrations rising to 630 .smol/l, plasma sodium to 156 mmol/l, and blood urea to 22 mmol/l. There was no proteinuria. The expected side effects of interferon treatment, lymphopenia and hepatotoxicity, were not serious, but the hyperkalaemia of the second patient was probably fatal. This infrequent complication has been reported by Rohatiner et al. 40 Rapid confirmation of the diagnosis of rabies is essential if other treatment regimens are to be tried in patients with early signs of encephalitis. We found that antigen detection by immunofluorescence of a skin biopsy specimen was as reliable as an immunofluorescence test on a brain smear at necropsy. '4 Blenden et al also advocate this technique. 4' In conclusion, the use of interferon alfa or tribavirin alone does not influence the course of rabies encephalitis. The use of these and other compounds such as tungstoantimoniate derivatives2 in combination may yet effect a cure. The only treatment that has been effective after the onset of clinical rabies encephalitis is intrathecal vaccination with a live attenuated rabies virus in dogs.4' A more attenuated virus, which is apathogenic when injected intrathecally into monkeys, is now available4' and may be used in humans in the future.
